INDICATED PREVENTION OF PSYCHOTIC DISORDERS WITH LONG-CHAINOMEGA-3 FATTY ACIDS: A RANDOMIZED, PLACEBO-CONTROLLED TRIAL

@article{Amminger2008INDICATEDPO,
  title={INDICATED PREVENTION OF PSYCHOTIC DISORDERS WITH LONG-CHAINOMEGA-3 FATTY ACIDS: A RANDOMIZED, PLACEBO-CONTROLLED TRIAL},
  author={G. Paul Amminger and Miriam R. Sch{\"a}fer and Konstantinos Papageorgiou and Susy Harrigan and Sue Cotton and Patrick D. McGorry and Gregor Berger},
  journal={Schizophrenia Research},
  year={2008},
  volume={102}
}
Research in people with psychosis risk syndrome: a review of the current evidence and future directions.
TLDR
The translation of the concept of a clinically identifiable PRS into clinical practice does not seem justified at this point, and results from intervention studies are encouraging, but are currently still insufficient to make treatment recommendations for this early, relatively non-specific illness phase.
Studying biomarkers in populations at genetic and clinical high risk for psychosis
TLDR
The final author version and the galley proof are versions of the publication after peer review that features the final layout of the paper including the volume, issue and page numbers.
How should we intervene in psychosis risk syndromes?
TLDR
A staged approach to intervention in PRS is recommended that only uses antipsychotic medication after other, more benign approaches have been tried, due to the high level of false positives and the lack of definitive evidence about effectiveness.
Studies on Paliperidone in OROS Tablets: Extraction Procedure and Chromatographic Analysis
A stability-indicating liquid chromatographic (LC) method was studied for the determination of paliperidone in osmotic-controlled release oral delivery system (OROS) tablets. A tablet extraction
Rationale for clinical interventions in prodromal psychosis. Are such interventions safe?
TLDR
Omega fatty acids and Cognitive Behavioural Therapy are certainly good adjuvant treatments for suspected prodromal psychosis and with further evidence they may be considered appropriate to use as monotherapy, particularly in the early prodrome.
Beyond the first episode: Candidate factors for a risk prediction model of schizophrenia
  • B. Murphy
  • Medicine, Psychology
    International review of psychiatry
  • 2010
TLDR
There are a number of known or putative genetic and environmental risk factors that have the potential to improve prognostication, though a multivariate risk prediction model combining them with clinical characteristics has yet to be developed.
Editorial: Developmental transitions to psychopathology: from genomics and epigenomics to social policy.
  • J. Leckman, M. Yazgan
  • Psychology, Medicine
    Journal of child psychology and psychiatry, and allied disciplines
  • 2010
TLDR
The focus of this annual review issue is the importance and the current status of prodrome research, and how the child’s genetic endowment, prenatal environment, temperamental predisposition, early parenting, peer relationships, and larger social and intergenerational environments shape and mold the child's behavior and the relevant neural pathways over the course of development.
Early intervention in patients at ultra high risk of psychosis: benefits and risks
TLDR
The aim of this review was to examine whether interventions in the prodromal phase have a favourable benefit/risk ratio.